Pulmicort and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pulmicort (budesonide) and Cyclophosphamide (cyclophosphamide). Common drug interactions include hair colour changes among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Pulmicort and Cyclophosphamide. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.

On Aug, 11, 2026

61 people who take Pulmicort and Cyclophosphamide together, and have interactions are studied.

Pulmicort and Cyclophosphamide drug interactions.

What are the common drug interactions of Pulmicort and Cyclophosphamide, by gender? *:

female:

Hair colour changes
Hair disorder
Hepatic enzyme increased
Hepatic failure (liver failure)
Herpes virus infection
Hypoaesthesia (reduced sense of touch or sensation)
Hypokinesia (decreased bodily movement)
Influenza
Interstitial lung disease
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)

male:

Neutropenia (an abnormally low number of neutrophils)
Febrile neutropenia (fever with reduced white blood cells)
Aplasia (defective development or congenital absence of an organ or tissue)
Bradycardia (abnormally slow heart action)
Hypertension (high blood pressure)
Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood creatinine increased

What are the common drug interactions of Pulmicort and Cyclophosphamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Ascites (accumulation of fluid in the abdominal cavity)
Bk virus infection
Hepatitis (inflammation of the liver)
Mycoplasma infection (bacterial infection)
Pancreatitis (inflammation of pancreas)
Parainfluenzae virus infection
Pleural effusion (water on the lungs)
Pneumonia
Febrile neutropenia (fever with reduced white blood cells)
Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)

10-19:

Bradycardia (abnormally slow heart action)
Hypertension (high blood pressure)

20-29:

n/a

30-39:

Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Dyspepsia (indigestion)
Fatigue (feeling of tiredness)
Infusion related reaction
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
Pain
Stem cell transplant
Tooth disorder (tooth disease)

40-49:

Asthenia (weakness)
Cough
Gastritis viral (inflammation of stomach due to viral infection)
Malaise (a feeling of general discomfort or uneasiness)
Respiratory rate increased (excess breathing rate/min)
Visual acuity reduced (reduced clearness of vision)
Weakness
Retinal haemorrhage (bleeding from retina)
Diarrhoea
Haemoglobin decreased

50-59:

Neutropenia (an abnormally low number of neutrophils)
Febrile neutropenia (fever with reduced white blood cells)
Pyrexia (fever)
Thrombocytopenia (decrease of platelets in blood)
Alopecia (absence of hair from areas of the body)
Back pain
Pain in extremity
Pulmonary embolism (blockage of the main artery of the lung)
Acute monocytic leukaemia (a type of blood cancer)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)

60+:

Febrile neutropenia (fever with reduced white blood cells)
Dyspnoea (difficult or laboured respiration)
Neurological symptom (symptoms of nervous system disease)
Obliterative bronchiolitis (bronchiolar inflammation)
Pain
Peripheral swelling
Photosensitivity reaction
Rash
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Sleep disorder

What are the existing conditions these people have? *

Burkitt Lymphoma (cancer of the lymphatic system): 10 people, 16.39%
Breast Cancer: 8 people, 13.11%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 7 people, 11.48%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 9.84%
Hypokalemia (low potassium): 6 people, 9.84%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.56%
Constipation: 4 people, 6.56%
Breast Cancer Female: 4 people, 6.56%
Bone Marrow Conditioning Regimen: 4 people, 6.56%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 6.56%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and Cyclophosphamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously